Marina J White, MD
Urology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. White’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A72339 · Current
Licensed to practise in California · since 2000 · expires 2027-08-31 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$61,177
Medicare paid this office $61,177 for 176 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of bladder and urethra using an endoscope | 69 | $17,717 | $250 |
| Return visit (30+ min) | 82 | $13,423 | $115 |
| Long return visit (40+ min) | 48 | $9,984 | $172 |
| New patient visit (60+ min) | 43 | $8,618 | $200 |
| New patient visit (45+ min) | 46 | $6,645 | $144 |
See all 8 services
| Diagnostic exam of bladder and urethra using an endoscope | 69 | $17,717 | $250 |
| Return visit (30+ min) | 82 | $13,423 | $115 |
| Long return visit (40+ min) | 48 | $9,984 | $172 |
| New patient visit (60+ min) | 43 | $8,618 | $200 |
| New patient visit (45+ min) | 46 | $6,645 | $144 |
| Short return visit (20+ min) | 35 | $2,608 | $67 |
| Ultrasound measurement of bladder capacity after voiding | 105 | $1,529 | $12 |
| Automated urinalysis test | 71 | $196 | $2 |
Who their Medicare patients are
176 Original Medicare patients in 2024. Average age 76 · Women 65% · Also on Medicaid 7% · Health risk score 0.82. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 70% · Coronary heart disease 24% · Diabetes 18% · Chronic kidney disease 16% · Atrial fibrillation 16% · Cancer 13% · Depression 13% · Heart failure 10% · COPD 6%.
The office billed $240,350, Medicare allowed $80,395 and paid $61,177; for 607 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 176 | 607 | 76 | 0.82 | $240,350 | $61,177 |
| 2023 | 194 | 585 | 77 | 0.95 | $207,914 | $55,522 |
| 2022 | 128 | 410 | 77 | 1.06 | $140,212 | $38,256 |
| 2021 | 238 | 906 | 75 | 1.06 | $242,508 | $64,020 |
| 2020 | 65 | 877 | 76 | 1.13 | $45,318 | $11,914 |
| 2019 | 49 | 169 | 80 | 1.13 | $27,683 | $10,906 |
| 2018 | 80 | 361 | 77 | 1.11 | $63,022 | $25,085 |
| 2017 | 62 | 375 | 77 | 1.16 | $56,253 | $20,492 |
| 2016 | 93 | 462 | 79 | 1.32 | $53,170 | $23,043 |
| 2015 | 47 | 189 | 79 | 0.99 | $26,064 | $10,207 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 96 | $15,929 | $121 |
| New patient visit (45+ min) | 103 | $15,653 | $152 |
| Diagnostic exam of bladder and urethra using an endoscope | 50 | $13,361 | $257 |
| Short return visit (20+ min) | 50 | $4,502 | $74 |
| Long return visit (40+ min) | 15 | $2,576 | $172 |
| Ultrasound measurement of bladder capacity after voiding | 100 | $1,490 | $11 |
| Automated urinalysis test | 54 | $136 | $2 |
2022: 6 services
| New patient visit (45+ min) | 78 | $12,044 | $154 |
| Diagnostic exam of bladder and urethra using an endoscope | 35 | $9,098 | $260 |
| Return visit (30+ min) | 55 | $8,632 | $118 |
| Short return visit (20+ min) | 36 | $3,971 | $86 |
| Ultrasound measurement of bladder capacity after voiding | 85 | $1,301 | $11 |
| Automated urinalysis test | 15 | $38 | $2 |
2021: 14 services
| Insertion of lower leg neurostimulator electrode | 26 | $10,263 | $118 |
| Diagnostic exam of bladder and urethra using an endoscope | 43 | $10,107 | $230 |
| New patient visit (45+ min) | 69 | $9,783 | $142 |
| Return visit (30+ min) | 77 | $9,269 | $108 |
| Long return visit (40+ min) | 46 | $6,909 | $138 |
| Short return visit (20+ min) | 48 | $4,051 | $76 |
| New patient visit (60+ min) | 14 | $2,254 | $161 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $2,173 | $21 |
| Short return visit | 31 | $1,724 | $49 |
| New patient visit (30+ min) | 18 | $1,490 | $83 |
| Insertion of temporary bladder tube | 14 | $676 | $42 |
| Manual urinalysis test with examination using microscope, automated | 77 | $342 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 19 | $238 | $11 |
| Automated urinalysis test | 30 | $70 | $2 |
2020: 4 services
| New patient visit (45+ min) | 23 | $3,223 | $140 |
| Long return visit (40+ min) | 17 | $2,261 | $126 |
| Return visit (30+ min) | 11 | $1,059 | $96 |
| Manual urinalysis test with examination using microscope, automated | 22 | $82 | $3 |
2019: 2 services
| Return visit (30+ min) | 33 | $4,829 | $85 |
| Urinalysis, manual test | 20 | $78 | $3 |
2018: 7 services
| Long return visit (40+ min) | 35 | $6,292 | $126 |
| New patient visit (60+ min) | 31 | $5,217 | $168 |
| Return visit (30+ min) | 32 | $3,883 | $84 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $2,236 | $149 |
| Ultrasound measurement of bladder capacity after voiding | 34 | $640 | $16 |
| Urinalysis, manual test | 41 | $188 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $29 | None |
2017: 8 services
| Return visit (30+ min) | 43 | $6,478 | $90 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $2,432 | $143 |
| Long return visit (40+ min) | 12 | $2,226 | $111 |
| New patient visit (60+ min) | 14 | $2,190 | $156 |
| New patient visit (45+ min) | 18 | $1,979 | $110 |
| Ultrasound measurement of bladder capacity after voiding | 39 | $1,026 | $18 |
| Urinalysis, manual test | 36 | $213 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 18 | $43 | None |
2016: 5 services
| Return visit (30+ min) | 51 | $7,996 | $101 |
| New patient visit (45+ min) | 22 | $3,035 | $138 |
| Long return visit (40+ min) | 16 | $2,268 | $133 |
| Ultrasound measurement of bladder capacity after voiding | 37 | $831 | $19 |
| Urinalysis, manual test | 53 | $228 | $3 |
2015: 4 services
| New patient visit (30+ min) | 17 | $1,603 | $94 |
| Short return visit (20+ min) | 18 | $1,505 | $68 |
| Ultrasound measurement of bladder capacity after voiding | 30 | $725 | $20 |
| Urinalysis, manual test | 23 | $136 | $3 |
Drugs they prescribed that Part D paid
$33,245
Pharmacies billed $33,245 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 282) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
247 generic and 35 brand-name prescriptions · $33,245 in drug cost · 58 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 20 | $18,105 | $905 |
| Methenamine Hippurate | 27 | $2,057 | $76 |
| Estradiol | 31 | $1,916 | $62 |
| Tamsulosin | 68 | $892 | $13 |
| Finasteride | 30 | $295 | $10 |
See all 6 drugs
| Myrbetriq | 20 | $18,105 | $905 |
| Methenamine Hippurate | 27 | $2,057 | $76 |
| Estradiol | 31 | $1,916 | $62 |
| Tamsulosin | 68 | $892 | $13 |
| Finasteride | 30 | $295 | $10 |
| Cephalexin | 36 | $171 | $5 |
Year by year
| 2024 | 282 | 109 | 0% (0) | 12% | $33,245 |
| 2023 | 267 | 104 | 0% (0) | None | $58,300 |
| 2022 | 245 | 81 | 0% (0) | 36% | $64,405 |
| 2021 | 207 | 103 | 0% (0) | 37% | $55,040 |
| 2020 | 27 | 18 | 0% (0) | None | $4,593 |
| 2019 | 54 | 20 | 0% (0) | 54% | $12,580 |
| 2018 | 54 | 21 | None | None | $7,198 |
| 2017 | 73 | 22 | 0% (0) | None | $5,709 |
| 2016 | 33 | 16 | None | 39% | $4,872 |
| 2015 | 21 | None | None | None | $2,948 |
| 2014 | 29 | 11 | 0% (0) | None | $2,598 |
| 2013 | 100 | 42 | 0% (0) | None | $7,144 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Myrbetriq | 44 | $27,663 | $629 |
| Elmiron | 11 | $8,916 | $811 |
| Methenamine Hippurate | 16 | $2,684 | $168 |
| Yuvafem | 11 | $2,500 | $227 |
| Estradiol | 19 | $2,408 | $127 |
| Tamsulosin | 63 | $1,664 | $26 |
| Cephalexin | 32 | $226 | $7 |
| Finasteride | 11 | $130 | $12 |
2022: 8 drugs
| Myrbetriq | 52 | $42,598 | $819 |
| Elmiron | 15 | $11,233 | $749 |
| Estradiol | 24 | $2,545 | $106 |
| Methenamine Hippurate | 13 | $2,252 | $173 |
| Oxybutynin Chloride Er | 20 | $1,327 | $66 |
| Tamsulosin | 38 | $516 | $14 |
| Finasteride | 16 | $238 | $15 |
| Cephalexin | 25 | $203 | $8 |
2021: 7 drugs
| Myrbetriq | 39 | $33,067 | $848 |
| Elmiron | 14 | $10,312 | $737 |
| Estradiol | 31 | $3,131 | $101 |
| Oxybutynin Chloride Er | 14 | $896 | $64 |
| Nitrofurantoin Mono-Macro | 13 | $359 | $28 |
| Cephalexin | 34 | $166 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $83 | $7 |
2019: 1 drug
| Myrbetriq | 21 | $8,379 | $399 |
2017: 3 drugs
| Oxybutynin Chloride | 11 | $362 | $33 |
| Cephalexin | 12 | $161 | $13 |
| Sulfamethoxazole-Trimethoprim | 11 | $54 | $5 |
2014: 1 drug
| Finasteride | 16 | $1,753 | $110 |
2013: 3 drugs
| Finasteride | 40 | $4,372 | $109 |
| Tamsulosin | 26 | $1,155 | $44 |
| Terazosin | 29 | $498 | $17 |
Money from drug and device companies
$164 in 2025
| 2025 | 2 | 2 | None | $164 |
| 2019 | 1 | 2 | None | $38 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Padcev | $115 | 1 payment
|
| Valencia Technologies | Ecoin Device Kit | $49 | 1 payment
|
See all 2 published payments
| Astellas Pharma US | Meals · 2025-11-05 | Padcev | $115 |
| Valencia Technologies | Meals · 2025-08-15 | Ecoin Device Kit | $49 |
See earlier years (2019)
2019: $38
| Allergan | Botox | $38 | 2 payments
|
Professional record
- NPI
- 1538247200
- Licence
- CA A72339California A72339: Current · expires 2027-08-31
- Trained
- Medical College of Wisconsin, 1998
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A723390
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Circle, Los Altos, CA, 94022
- NPI first listed
- 2006-11-01
- NPI last updated
- 2023-03-15
- NPI record certified
- 2023-03-15
This is when the NPI record was last certified, not a medical board exam.